UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 134

Sortiert nach

Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance

Cancers, 2018-12, Vol.10 (12), p.482

2018

Link zum Volltext

Verfügbarkeit prüfen

Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis

International journal of molecular sciences, 2012-08, Vol.13 (8), p.9959-9970

2012

Link zum Volltext

Verfügbarkeit prüfen

Disabled-2 ( DAB2 ): A Key Regulator of Anti- and Pro-Tumorigenic Pathways

International journal of molecular sciences, 2022-12, Vol.24 (1), p.696

2022

Link zum Volltext

Verfügbarkeit prüfen

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism

Journal of translational medicine, 2022-12, Vol.20 (1), p.556-556, Article 556

2022

Link zum Volltext

Verfügbarkeit prüfen

Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer

Cellular and molecular life sciences : CMLS, 2023-11, Vol.80 (11), p.320-320, Article 320

2023

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer

BMC cancer, 2013-10, Vol.13 (1), p.476-476, Article 476

2013

Link zum Volltext

Verfügbarkeit prüfen

Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics

Cancer letters, 2018-05, Vol.421, p.51-58

2018

Link zum Volltext

Verfügbarkeit prüfen

The Role of Annexin A2 in Tumorigenesis and Cancer Progression

Cancer microenvironment, 2011-08, Vol.4 (2), p.199-208

2011

Link zum Volltext

Verfügbarkeit prüfen

Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer

Journal of experimental & clinical cancer research, 2019-01, Vol.38 (1), p.10-10, Article 10

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeting CDK9 for treatment of colorectal cancer

Molecular oncology, 2019-10, Vol.13 (10), p.2178-2193

2019

Link zum Volltext

Verfügbarkeit prüfen

Matrix Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MALDI MSI) for Monitoring of Drug Response in Primary Cancer Spheroids

Proteomics (Weinheim), 2019-11, Vol.19 (21-22), p.e1900146-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Reducing the Invasiveness of Low- and High-Grade Endometrial Cancers in Both Primary Human Cancer Biopsies and Cell Lines by the Inhibition of Aquaporin-1 Channels

Cancers, 2023-09, Vol.15 (18), p.4507

2023

Link zum Volltext

Verfügbarkeit prüfen

Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype

International journal of molecular sciences, 2020-12, Vol.22 (1), p.71

2020

Link zum Volltext

Verfügbarkeit prüfen

A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer

Gynecologic oncology, 2020-12, Vol.159 (3), p.827-838

2020

Link zum Volltext

Verfügbarkeit prüfen

Optical Fibre-Enabled Photoswitching for Localised Activation of an Anti-Cancer Therapeutic Drug

International journal of molecular sciences, 2021-10, Vol.22 (19), p.10844

2021

Link zum Volltext

Verfügbarkeit prüfen

4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer

Cancers, 2019-08, Vol.11 (8), p.1187

2019

Link zum Volltext

Verfügbarkeit prüfen

MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia

International journal of molecular sciences, 2016-07, Vol.17 (7), p.1088-1088

2016

Link zum Volltext

Verfügbarkeit prüfen

Erratum to “A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer” [Gynecologic Oncology 159 (2020) 827–838]

Gynecologic oncology, 2021-10, Vol.163 (1), p.215-215

2021

Link zum Volltext

Verfügbarkeit prüfen

Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer

Cancers, 2023-04, Vol.15 (7), p.2172

2023

Link zum Volltext

Verfügbarkeit prüfen

Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome

Translational research : the journal of laboratory and clinical medicine, 2016-05, Vol.171, p.83-95.e2

2016

Link zum Volltext

Verfügbarkeit prüfen

Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation

Clinical & experimental metastasis, 2015-06, Vol.32 (5), p.441-455

2015

Link zum Volltext

Verfügbarkeit prüfen

A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer

Cancers, 2020-12, Vol.13 (1), p.4

2020

Link zum Volltext

Verfügbarkeit prüfen

Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance

Oncotarget, 2017-03, Vol.8 (11), p.17819-17832

2017

Link zum Volltext

Verfügbarkeit prüfen

Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer

Frontiers in oncology, 2020-09, Vol.10, p.1767-1767

2020

Link zum Volltext

Verfügbarkeit prüfen

Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations

Cancers, 2022-06, Vol.14 (11), p.2763

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Englisch
(134)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance

Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis

Disabled-2 ( DAB2 ): A Key Regulator of Anti- and Pro-Tumorigenic Pathways

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism

Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer

Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics

The Role of Annexin A2 in Tumorigenesis and Cancer Progression

Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer

Targeting CDK9 for treatment of colorectal cancer

Matrix Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MALDI MSI) for Monitoring of Drug Response in Primary Cancer Spheroids

Reducing the Invasiveness of Low- and High-Grade Endometrial Cancers in Both Primary Human Cancer Biopsies and Cell Lines by the Inhibition of Aquaporin-1 Channels

Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype

A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer

Optical Fibre-Enabled Photoswitching for Localised Activation of an Anti-Cancer Therapeutic Drug

4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer

MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia

Erratum to “A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer” [Gynecologic Oncology 159 (2020) 827–838]

Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer

Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome

Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation

A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer

Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance

Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer

Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations

Suchergebnisse filtern